Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer.
Mahmoud GanjiShohreh BakhshiAlireza ShoariReza Ahangari CohanPublished in: Journal of translational medicine (2023)
These compounds can be considered as candidates for bladder cancer therapy with improved therapeutic properties and less adverse effects.